The medication is administered once weekly via subcutaneous injection, with doses typically initiated at 2.5 mg once weekly for 4 weeks, then escalated (e.g., to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg) based on response and tolerability as per the SmPC
Acosta To our knowledge, this is the first study assessing the association between previous use of anti-obesity medications and the weight loss outcomes of patients prescribed semaglutide for treatment of overweight or obesity, Andres J
This add-on helps support your immune system, energy levels, skin health, and overall wellness
Easier weight regain: Once calories increase, fat can come back faster
Why Tackling Weight Matters Excess weight can heighten risks for numerous health issues, such as type 2 diabetes, sleep apnea, heart disease, and even certain cancers
" Concerns About Telehealth Platforms Telehealth platforms face similar scrutiny, such as concerns about overprescribing or inadequate screening